The trophectoderm (TE) is the first epithelium to be generated during mammalian early development. The TE works as a barrier that isolates the inner cell mass from the uterine environment and provides the turgidity of the blastocyst through elevated hydrostatic pressure. In this study, we investigated the role of tight junctions (TJs) in the barrier function of the TE during mouse blastocyst formation. RT-PCR and immunostaining revealed that the mouse TE expressed at least claudin 4, 6, and 7 among the 24 members of the claudin gene family, which encode structural and functional constituents of TJs. When embryos were cultured in the presence of a GST-fused C-terminal half of Clostridium perfringens enterotoxin (GST-C-CPE), a polypeptide with inhibitory activity to claudin 4 and 6, normal blastocyst formation was remarkably inhibited; the embryos had no or an immature blastocoel cavity without expansion, and blastomeres showed a rounded shape. In these embryos, claudin 4 and 6 proteins were absent from TJs and the barrier function of the TE was disrupted; however the basolateral localization of the Na + /K + -ATPase α1 subunit and aquaporin 3, which are thought to be involved in blastocyst formation, appeared normal. These results clearly demonstrate that the barrier function of TJs in the TE is required for normal blastocyst formation.
Introduction
The epithelium plays fundamental roles in the architecture of metazoans. It primarily separates the body environment from its external environment. In the body, epithelial structures are involved in the establishment and maintenance of distinct fluid compartments, which are required for development as well as for the physiological functions of various organs. To accomplish these functions, epithelial cellular sheets not only selectively transport substances via transporter proteins within the plasma membrane, but also work as barriers to separate these compartments.
The first epithelial structure that emerges during mammalian early development is the trophectoderm (TE) epithelium, which covers the surface of the blastocyst and encloses the inner cell mass (ICM). Mouse TE differentiation begins at the morula stage of an 8-cell embryo when strong intercellular adhesion (compaction) by E-cadherin occurs accompanied by cell polarization (Shirayoshi et al., 1983; Vestweber and Kemler, 1984) . Then, by the 32-cell stage during blastocyst formation, the outer blastomeres acquire complete epithelial characteristics to form the TE, which encloses the ICM and generates the blastocoel cavity by vectorial transport of ions, water, and other small molecules (reviewed by Fleming et al., 2001; Biggers et al., 1988; Watson et al., 2004) . In the blastocyst, the blastocoel cavity is filled with blastocoelic fluid, providing the ICM with a unique environment separated from the outer uterine environment.
To date, several membrane transporters that are expressed in the TE have been demonstrated to be essential molecular mechanisms for blastocyst formation. Na + transport by the TE in a TE-to-blastocoel direction establishes ionic gradients across the TE, leading to the accumulation of fluid within the blastocoel cavity and providing the turgidity of the blastocyst owing to the elevated hydrostatic pressure. The trans-TE ionic gradient formation appears to be driven by Na + /K + -ATPases located within the basolateral membrane domains of the TE (reviewed by Biggers et al., 1988; Kidder, 2002; Watson et al., 2004) . When Na + /K + -ATPase activity is blocked by ouabain, a specific inhibitor of this enzyme, normal blastocyst formation is blocked in vitro (Biggers et al., 1978) . Further evidence indicating the involvement of Na + /K + -ATPases in this process is the finding that blastocyst expansion is retarded in the absence of extracellular Na + (Manejwala et al., 1989) . Multiple isoforms of alpha-and beta-subunits of Na + /K + -ATPase are expressed in murine preimplantation embryos, and they appear to show functional redundancy (MacPhee et al., 2000; Barcroft et al., 2004) . In the apical membrane domain, the NHE-3 Na + / H + -exchanger (Kawagishi et al., 2004) , Na + /glucose (Wiley et al., 1991) , and Na + /amino acid cotransporter (DiZio and Tasca, 1977) , as well as amiloride-sensitive Na + channels (Powers et al., 1977) , seem to participate in the uptake of Na + into the TE to support the activity of Na + /K + -ATPases. Another important membrane transporter involved in blastocyst formation is the aquaporin water channel (Barcroft et al., 2003) . Although fluid transport during blastocyst formation has been attributed to the process of simple diffusion, several studies have indicated that the osmotic gradient across the TE layer is relatively shallow Biggers et al., 1988) . Rapid fluid flow during cavitation driven by a small osmotic gradient suggests the existence of channel-mediated water flow across the TE (Barcroft et al., 2003) . In murine blastocysts, aquaporin 3 and 8 are localized at the basolateral membrane domains of the TE, while aquaporin 9 occurs within its apical membrane domains (Barcroft et al., 2003) . Treatment of blastocysts with a mercuric compound p-chloromercuriphenylsulfonic acid, an inhibitor of aquaporins, impairs the volume recovery of murine blastocysts shrunk by exposure to a hyperosmotic solution (Barcroft et al., 2003) , supporting the hypothesis that aquaporin mediates trans-TE water transport during blastocyst formation.
In addition to these membrane transporters directly involved in the accumulation of blastocoelic fluid, a permeability seal between TE cells by tight junctions (TJs), one form of epithelial and endothelial cell-to-cell junction, is thought to be a prerequisite for blastocyst formation. If the TJ seal is insufficient, transported materials might easily leak back through the paracellular space and expansion of the blastocoel cavity would never occur. TJs circumscribe individual cells as belts to seal the intercellular space of adjacent cells and create permeability barriers by restricting the diffusion of solutes through the paracellular pathway (Tsukita et al., 2001; Schneeberger and Lynch, 2004; Van Itallie and Anderson, 2005) . TJs are complexes composed of integral membrane proteins and peripheral membrane proteins. Occludin, claudins, tricellulin, and JAM family members have all been identified as TJ-associated integral membrane proteins (Furuse et al., 1993 (Furuse et al., , 1998a Ikenouchi et al., 2005; Martin-Padura et al., 1998) . Among these, claudins play central roles in the architecture and barrier function of TJs. Claudins, 22-33 kDa in size, are predicted to have four transmembrane domains and comprise a multi-gene family with 24 members in mice and humans (Morita et al., 1999a; Wilcox et al., 2001) . Claudins constitute the backbone structure of TJs, not only by associating with each other as adhesion molecules between adjacent cells, but also by polymerizing into fibril-like structures in the plasma membrane, so-called TJ strands, which circumscribe cells as permeability seals (Furuse et al., 1998b) . In most cell types, multiple claudin types are co-expressed in individual cells forming TJ strands as a mosaic of different claudins . Furthermore, the combination and mixing ratio of claudin types differ among types of epithelial or endothelial cells, and accumulating evidence has established a concept that heterogeneity in claudin content creates functional diversity in the barrier property of TJs, such as conductance and charge selectivity, depending on the physiological requirements of cell types (Van Itallie and Anderson, 2005; Furuse and Tsukita, 2006) . Various claudin family genes have been disrupted in mice, and these mice exhibited dysfunction of epithelial or endothelial barriers, including the epidermal barrier (Furuse et al., 2002) , blood-brain barrier (Nitta et al., 2003) , blood-testis barrier (Gow et al., 1999) , cochlear barrier (Ben-Yosef et al., 2003; Kitajiri et al., 2004) , myelin barrier (Gow et al., 1999; Miyamoto et al., 2005) , and others. Furthermore, recent positional cloning studies have identified mutations of the genes encoding tight junction proteins in several human hereditary diseases (Simon et al., 1999; Wilcox et al., 2001; Hadj-Rabia et al., 2004; Riazuddin et al., 2006) . These studies not only indicate that claudins play crucial roles in epithelial and endothelial barriers in vivo, but also imply that claudins are specific targets through which the barrier function of TJs can be modified.
The differentiation of TJs in the TE during mouse preimplantation embryogenesis has been reported in detail by thinsection and freeze-fracture replica electron microscopy Magnuson et al., 1977; Sheth et al., 2000) . Furthermore, Fleming and colleagues have intensively analyzed the assembly of various TJassociated proteins, including two alternatively spliced forms of ZO-1, as well as cingulin, occludin, and JAM, by immunofluorescence microscopy (reviewed in Fleming et al., 2000; Thomas et al., 2004) . These studies have revealed that TJs emerge at around the late morula stage and are mature by the 32 cell stage of blastocyst formation. However, to date, there has been no experimental evidence that directly demonstrates the function of TJs in blastocyst formation.
In this study, we investigated the role of the barrier function of TJs in the TE during blastocyst formation in mouse early embryogenesis. To modulate the barrier function of TJs, we used the C-terminal half of Clostridium perfringens enterotoxin (C-CPE), which binds to the extracellular domain of some claudin family members including claudin 3, 4, 6, 7, 8, and 14 (Sonoda et al., 1999; Fujita et al., 2000) . We examined the expression of claudins in the mouse TE and confirmed that a glutathione S-transferase fusion protein with C-CPE (GST-C-CPE) bound to claudin 4 and 6 among TE-associated claudins.
In the presence of GST-C-CPE, in vitro-cultured mouse embryos normally developed to compact morulae, but blastocyst expansion was inhibited, which is accompanied by the removal of claudin 4 and 6 from TJs in the TE, and disruption of its barrier function. These findings indicate for the first time that the barrier function of TJs in the TE is required for normal blastocyst formation. This study also suggests an involvement of the barrier function of TJs in the morphogenetic events caused by hydrostatic pressure during developmental processes.
Materials and methods

Antibodies
Rat anti-mouse occludin monoclonal antibody (mAb) (MOC37) and rabbit anti-mouse claudin 6 polyclonal antibodies (pAb) were raised and characterized as described previously (Saitou et al., 1997; Morita et al., 1999b) . Mouse anti-HA-tag mAb (12CA5), mouse anti-human claudin 4 mAb (3E2C1), mouse antihuman Oct3/4 mAb (C-10), mouse anti-human Cdx2 mAb, and mouse antihuman Na + /K + -ATPase α1 subunit mAb (C464.6) were purchased from Boehringer Mannheim (Indianapolis, IN, USA), Zymed Labs (San Francisco, CA, USA), BioGenex Inc. (San Ramon, CA, USA), Santa Cruz (San Francisco, CA, USA), and Upstate Biotechnology (Lake Placid, NY, USA), respectively. Rabbit anti-mouse Cdx2 pAb, rabbit anti-mouse Nanog pAb, rabbit antiaquaporin 3 pAb, rabbit anti-CPE pAb, and rabbit anti-mouse claudin 12 pAb (Fujita et al., 2006) were kindly provided by Drs. Taketo M. M. (Kyoto University, Japan), Yamanaka S. (Kyoto University, Japan), Takata K. (Gunma University, Japan), Y. Horiguchi (Osaka University, Japan), and H. Chiba (Sapporo Medical University School of Medicine, Japan), respectively. To produce rabbit anti-mouse claudin 7 pAb, the peptide CKAAYRAPR-SYPKSNSSKEYV, corresponding to the C-terminal cytoplasmic domain of mouse claudin 7, was synthesized and coupled via cysteine to keyhole limpet hemocyanin. This conjugated peptide was used as an antigen to generate pAb in rabbits. The antiserum was affinity purified using a glutathione S-transferase (GST) fusion protein with the C-terminal cytoplasmic domain of claudin 7. The specificities of anti-claudin 4, 6, and 7 antibodies were confirmed by immunoblotting of the GST fusion proteins of the C-terminal cytoplasmic regions of claudins 1-24 and by immunofluorescence staining of mouse L fibroblasts transiently expressing claudin types (Fig. S1 ).
Embryo collection and culture
To obtain enough embryos that are synchronized at each developmental stage for immunostaining experiments with various antibodies, we generated embryos by in vitro fertilization (IVF) rather than flushing in vivo-derived embryos from the oviducts. C57BL/6J 9-to 11-week-old female mice were superovulated by intraperitoneal injection of 6.7 IU Pregnant Mare Serum gonadotrophin (PMS; Teikoku Zouki, Japan) followed 56 h later by intraperitoneal injection of 6.7 IU human chorionic gonadotrophin (hCG; Teikoku Zouki, Japan). After a further 15 h, oocytes were collected from unmated mice and fertilized in Human Tubal Fluid (HTF) medium containing 0.4% of bovine serum albumin (BSA; Sigma) by IVF. IVF embryos were cultured in modified Whitten's medium (110 mM NaCl, 4.78 mM KCl, 1.19 mM MgSO 4 ·7H 2 O, 22. 6 mM NaHCO 3 , 5.56 mM glucose, 0.226 mM sodium pyruvate, 1.50 mM calcium lactate, 2 μM 2-mercaptoethanol, 50 μM EDTA·2Na) containing 0.3% of BSA, F-V (Nacalai Tesque, Japan) in 5% CO 2 at 37°C. For GST-C-CPE or GST-C-CPE313 treatment, these proteins were added to the culture medium at 100 μg/ml. The culture medium was changed to fresh medium every 24 h.
Production of GST-C-CPE fusion proteins
DNA fragments encoding the C-terminal half of CPE (aa 184-319) and its deletion mutant (aa 184-313) were amplified from the template plasmid DNA containing the full length of CPE (kindly provided by Dr. Y. Horiguchi) using primer pairs 5′-cgcggatccAGATGTGTTTTAACAGTTCCA-3′/5′-gggctcgagT-TAAAATTTTTGAAATAATAT-3′ and 5′-gaattcAGATGTGTTTTAACAGTT-CCATC-3′/5′-gaattcTCATGAATAAGGGTAATTTCCACT-3′, respectively, and subcloned into pGEX6P-1 vector (Amersham Pharmacia Biotech, Buckinghamshire, UK). The obtained fusion protein products were designated GST-C-CPE and GST-C-CPE313, respectively. These GST fusion proteins were generated in E. coli and purified using glutathione-Sepharose 4B beads (Amersham Pharmacia Biotech). Eluted GST fusion proteins were dialyzed against PBS at 4°C and used for experiments.
RNA isolation and RT-PCR
Total RNA was isolated from E4.0-stage embryos using an RNeasy micro kit (QIAGEN). RNA was reverse transcribed using Superscript II reverse transcriptase, according to the manufacturer's instructions (Invitrogen), and the firststrand cDNA (0.25 embryo/sample) or 6 × 10 4 copy of plasmid DNA containing each claudin cDNA was amplified by PCR using specific primers for each claudin. Amplified DNA fragments were analyzed by agarose gel electrophoresis. The primers used for RT-PCR are shown in Table 1 
Binding assay of GST-C-CPEs
GST-C-CPE binding activity to claudins was detected by flow cytometry as follows. Briefly, HEK293 cells transiently transfected with claudin genes were dissociated into single cells and incubated with culture medium containing GST-C-CPEs (20 μg/ml) for 15 min on ice. Cells were then washed twice with PBS containing 0.1% BSA and stained with an anti-CPE pAb followed by Alexa Flour 488-labeled anti-rabbit IgG (Molecular Probes). GST-C-CPE binding to cells was evaluated using an EPICS flow cytometer (Beckman Coulter).
Immunofluorescence microscopy and functional barrier assay
Embryos cultured in the presence or absence of GST-C-CPEs were fixed with 3.7% formaldehyde for 20 min at room temperature (for labeling of Cdx2 and Oct3/4) or cold 10% trichloroacetic acid (TCA) for 15 min on ice (for the others). Embryos were then washed twice with 0.1% TritonX-100 in PBS and permeabilized in 0.1% TritonX-100 in PBS for 10 min at room temperature. After blocking with 3% BSA in PBS, they were incubated in antigen-specific antibody at 4°C overnight, washed as described above, and incubated in fluorescence-conjugated secondary antibody for 1 h at room temperature. Stained embryos were examined using a Zeiss LSM510META confocal laser scanning microscope (Zeiss).
To examine the barrier function of the TE, embryos treated with GST-C-CPE or GST-C-CPE313 were incubated in mWM medium containing 1 mg/ml FITCdextran (4.4 kDa) (Sigma) for 10 min and observed immediately using a Zeiss LSM510META confocal laser scanning microscope (Zeiss).
Measurement of cell number and diameter of embryos
Embryos were fixed with 3.7% formaldehyde for 20 min at room temperature and cell nuclei were visualized with DAPI. These embryos were observed along the Z-axis every 2 μm using a DeltaVision microscope (Applied Precision) and the total number of cells in these embryos was counted. Measurement of the embryos' diameters was performed using phase-contrast microscopy.
Results
Expression of claudin family members during mouse blastocyst formation
The mouse claudin family consists of at least 24 genes, each of which has a unique tissue expression pattern, but little is known about what types of claudin constitute TJs in the mouse TE. To determine which claudins are expressed in the mouse early embryo, we analyzed transcripts isolated from several embryonic stages by RT-PCR. We found that claudin 4, 6, 7, and 12 were expressed at the precompact 8-cell stage (data not shown) and the blastocyst stage (E4.0) (Fig. 1A) . Protein expression of these claudins in mouse early embryos was confirmed by double immunofluorescence staining using antibodies to these claudins and occludin, whose concentration is a good marker for TJ formation. In the compact 8-cell stage, punctate staining of claudins and occludin was sometimes observed along the cell-cell contact region (Fig. S2) . By contrast, at the 16-cell stage, a continuous band of claudin 4, 6, and 7, and occludin around blastomeres was clearly observed (Fig. S2) . In blastocysts at E4.0, claudin 4, 6, and 7 were concentrated continuously at the most apical region of cell-cell contact planes in TEs co-localizing with occludin (Fig. 1B) , but no signal for these proteins was detected in the ICM. During these stages, there was no significant difference in the timing of their appearance into TJs among claudin 4, 6, and 7 (data not shown). Although the expression of claudin 12 mRNA was confirmed in RT-PCR (Fig. 1A) , the concentration of claudin 12 protein into TJs was not detected in immunofluorescence staining during these stages (data not shown). These results indicate that at least claudin 4, 6, and 7 constitute TJs in the TE during mouse blastocyst formation.
Binding of GST-C-CPE fusion protein to mouse claudin 4 and 6
Originally, claudin 3 and 4 were identified as the cellular receptors for CPE, C. perfringens enterotoxin (Katahira et al., 1997a,b) . CPE protein is divided into two domains: the NH 2 -terminal half with cytotoxicity and the C-terminal half with cellbinding activity. A recombinant C-terminal half of CPE (aa 184-319 of CPE; C-CPE) binds to these claudins without affecting cell viability (Katahira et al., 1997a) . We have previously shown that CPE binds to some claudin family members in addition to claudin 3 and 4 and that C-CPE hampers TJ formation in MDCK cells through down-regulation of claudin 4, thereby reducing the barrier function of the cellular sheet (Sonoda et al., 1999) . Our aim in this study was to disturb the function of TJs during mouse blastocyst formation, in vitro, by treatment with C-CPE. However, recombinant C-CPE tended to form aggregates, which made it difficult to control its concentration in solution in these experiments. Thus, we generated a recombinant GST-C-CPE fusion protein, which was highly soluble and did not aggregate during longer storage, and used it in further experiments. To examine whether or not GST-C-CPE binds to claudins that are expressed in the TE, claudin 4, 6, or 7 was transiently expressed in HEK293 cells, and the binding of GST-C-CPE to the surface of these cells was analyzed by immunofluorescence staining with an anti-CPE pAb. As shown in Fig. 2A , exogenous claudins were localized at the plasma membrane as well as the intracellular membrane compartments, and FACS analyses revealed that GST-C-CPE bound to HEK293 cells expressing claudin 4 and 6, but not to those expressing claudin 7 (Fig. 2B) , indicating that GST-C-CPE binds to claudin 4 and 6. GST-C-CPE did not bind to claudin 12, whose expression in the blastocyst was detected in RT-PCR but not in immunofluorescence microscopy (Fig. 1A) in the same assay (data not shown). The lack of GST-C-CPE binding to claudin 7 was inconsistent with our previous ob- (Fujita et al., 2000) . However, we confirmed that HEK293 cells overexpressing claudin 7 were also sensitive to full-length CPE (data not shown), indicating that full-length CPE could bind to claudin 7. The reason for this discrepancy is not clear, but one possible explanation is that the structural difference in the claudin-binding domains between full-length CPE and GST-C-CPE resulted in the difference in the compatibility of these peptides with claudin 7.
The receptor-binding domain of CPE has been reported to locate at the C-terminal region of this protein (Hanna et al., 1991) . Consistent with this notion, a GST-C-CPE mutant in which the C-terminal six amino acids were deleted (GST-C-CPE313) did not bind to HEK293 cells overexpressing claudin 4 or 6 in the same assay (Fig. 2B) . Therefore, we used GST-C-CPE313 as a negative control for GST-C-CPE, in terms of claudin binding, in further analyses.
Inhibition of blastocyst formation in GST-C-CPE-treated embryos
In normal embryos, compaction of 8-cell blastomeres occurred at E2.5. The blastocoel cavity then became clearly visible at E3.5, and it continued to expand accompanied by flattening of the TE cells throughout blastocyst formation. To disturb the normal functions of TJs during mouse blastocyst formation, mouse early embryos were cultured from the 4-cell stage in vitro in the presence of GST-C-CPE or GST-C-CPE313, and their morphology was examined by phase-contrast microscopy (Fig. 3A) . Prior to the analysis, we confirmed that GST-C-CPE and GST-C-CPE313, each with a molecular mass of ∼ 43 kDa, easily penetrated the zona pellucida and reached blastomeres when embryos were incubated in culture medium containing these recombinant proteins (Fig. S3A ). Embryos treated with GST-C-CPE313 as a negative control showed normal development in vitro throughout the culture period, similar to those with no treatment. By contrast, GST-C-CPE-treated embryos developed normally to compact morulae but failed to form a normal blastocyst. At E3.5, most GST-C-CPE-treated embryos had an undetectable or a very small blastocoel cavity. At E4.0, most embryos (96.4 ± 3.4%, n = 126) had an immature blastocoel cavity and blastomeres had a rounded shape, although cell division appeared to proceed normally. The remaining embryos had an obvious blastocoel cavity, with flattened blastomeres (Fig. 3B ), but these embryos never exhibited expansion and the Fig. 1 . Expression of claudins in mouse blastocysts. (A) RNA extracted from E4.0-stage mouse embryos was reverse transcribed and analyzed by PCR using specific primers for each claudin. DNA bands of claudin 4, 6, 7, and 12 were detected on agarose gel electrophoresis (RT+). No band was detected from RNA samples without the reverse transcriptase (RT−). In the same PCR condition, enough amounts of the DNA fragments of respective claudins were amplified from the template containing 6 × 10size of their blastocoel cavities was less than that of untreated or GST-C-CPE313-treated embryos. We designated these embryo types with rounded and flattened blastomeres at E4.0 as type I and type II embryos, respectively (Figs. 3A, B) . We also designated outer blastomeres in GST-C-CPE-treated embryos at the blastocyst stage as TE-like cells in this study.
The average cell number of GST-C-CPE-treated embryos reaching E4.0 was slightly less than that of control embryos reaching this stage (50.0 ± 6.87 vs 44.3 ± 7.35), indicating that GST-C-CPE treatment slightly reduced cell growth (Table 2) . However, the failure of normal blastocyst formation induced by GST-C-CPE treatment was not likely to be due to retardation of cell growth because even GST-C-CPE-treated embryos with over 50 cells at E4.0 failed to exhibit expansion of the blastocoel cavity although most control embryos with less than 50 cells showed blastocoel expansion at the same stage (data not shown). To exclude the influence of cell growth retardation in interpreting these data, the data were collected from GST-C-CPE-treated and GST-C-CPE313-treated groups of embryos with a cell number of 41-50 at E4.0, and the diameters of the embryos were compared. As shown in Table 2 , the diameter of GST-C-CPE-treated embryos was significantly less than that of control embryos, although the cell number was almost equal between these two groups, indicating that GST-C-CPE inhibited blastocyst formation in mouse embryos.
We then examined the critical point of GST-C-CPE action during blastocyst formation (Fig. 3C) . When GST-C-CPE was added to the culture medium at E3.0, embryos could not form a Fig. 2 . Binding of GST-C-CPE to claudins. (A) HEK293 cells transiently expressing HA-tagged claudin 4, 6, and 7 were stained with an anti-HA mAb. Exogenous claudins were localized at cell surface as well as intracellular membrane compartments. (B) HEK293 cells expressing each claudin were dissociated and incubated with GST-C-CPE or GST-C-CPE313. Cells were then fluorescently labeled with anti-CPE pAb and analyzed using a flow cytometer. GST-C-CPE bound to HEK293 cells expressing claudin 4 and 6 (arrows), but not to those expressing claudin 7. The binding of GST-C-CPE313, which is a deletion mutant of GST-C-CPE missing the Cterminal six amino acids, to these cells was not detected. Fig. 3 . Effects of GST-C-CPE on blastocyst formation in cultured mouse preimplantation embryos. (A) IVF-derived embryos were incubated in the presence of GST-C-CPE or GST-C-CPE313 (100 μg/ml each) from the 4-cell stage, and their morphology at each developmental stage was examined by phase-contrast microscopy. Embryos with no treatment and those treated with GST-C-CPE313 exhibited compaction at E2.75; blastocoel cavities became obvious at E3.5. By contrast, GST-C-CPE-treated embryos developed to compact morulae at E2.75 but failed to form a normal blastocyst at E3.5 and later stages. These embryos had rounded blastomeres and an immature blastocoel cavity. GST-C-CPE-treated embryos at E4.0 could be classified into two populations: type I and type II. Type I embryos had rounded blastomeres and undetectable or very small blastocoel. Type II embryos had smooth TE-like cells and an obvious blastocoel, but this never exhibited expansion. Arrowheads indicate the boundary of blastocoel cavity. (B) The proportion of type I and type II GST-C-CPE-treated embryos was 96.4% to 3.6% (±3.4%, n = 126), respectively. (C) GST-C-CPE was added to the culture medium at the indicated embryonic stage and the morphology of embryos was examined by phase-contrast microscopy. Embryos incubated with GST-C-CPE added at E3.0 failed to form a normal blastocyst. They had rounded blastomeres and blastocoel expansion was never observed until E5.5 (upper panel). By contrast, embryos incubated with GST-C-CPE added at E3.5 developed normally in further culture and showed blastocoel expansion (lower panel). (D) GST-C-CPE was added to the culture medium from the 4-cell stage and removed at E3.5. The embryos quickly formed a normal expanded blastocoel (E3.75) and hatched at E5.5. Scale bar, 20 μm. normal blastocoel cavity, and the size of embryos remained constant without expansion by E5.5. By contrast, when GST-C-CPE was added to the culture medium at E3.5, blastocyst formation was not affected although GST-C-CPE easily penetrates the zona pellucida and reaches the surface of blastomeres (Fig. S3B) , and embryos hatched at E5.5 like those without treatment. These results show that around E3.5 is the critical point for the action of C-CPE added to the culture medium. When GST-C-CPE added from the 4-cell stage was removed at E3.5, blastocyst formation, which was once retarded, resumed; the embryos formed normal blastocoel cavities at E3.75 and finally hatched at E5.5 (Fig. 3D) . This quick recovery of blastocyst expansion after removal of GST-C-CPE also supports our conclusion that the failure of blastocyst formation induced by GST-C-CPE-treated embryos is not because of the retardation of cell growth.
Disruption of the barrier function of the TE-like cells in GST-C-CPE-treated embryos
Next, we investigated the barrier function of the TE-like cells in embryos treated with GST-C-CPE. In vitro-cultured embryos at various embryonic stages were incubated in medium containing FITC-dextran of 4.4 kDa for 10 min and the influx of FITC-dextran into the blastocoel cavity was examined by confocal laser scanning fluorescence microscopy. In normal embryos without any treatment, tracer influx occurred at E3.0 but became undetectable at E3.5, showing that the barrier function of TJs in the TE to this tracer was established at around E3.5 (Fig. 4A) . However, in GST-C-CPE-treated embryos, FITC-dextran of 4.4 kDa infiltrated into the blastocoel cavity even at E4.0, indicating that the barrier function of the outer blastomeres was hampered by GST-C-CPE (Fig. 4B) . GST-C-CPE313 did not affect the barrier function of the TE. These results indicate that dysfunction of the barrier function of TJs in the TE is most likely participate in the inhibition of blastocyst formation in GST-C-CPE-treated mouse early embryo. Subcellular localization of claudins, occludin, Na + /K + -ATPase, and aquaporin in TE-like cells in GST-C-CPE-treated embryos To understand the molecular mechanism underlying the inhibition of blastocyst formation caused by the GST-C-CPE treatment, we next examined the subcellular localization of claudins and occludin expressed in the TE-like cells of GST-C-CPE-treated embryos by immunofluorescence confocal microscopy (Fig. 5) . In E4.0 embryos cultured in the presence of GST-C-CPE from the 4-cell stage, occludin was normally localized at cell-cell junctions delineating the TE-like cells. Claudin 7, which does not bind to GST-C-CPE, also showed normal distribution at TJs. By contrast, localization of claudin 4 and 6, which do bind to GST-C-CPE, were severely affected. They exhibited diffuse localization in the plasma membrane and the cytoplasm, and the concentrations of these claudins in cellcell junctions often disappeared, even though occludin staining remained normal (Fig. 5) . Abnormal localizations of claudin 4 and 6 were never observed in embryos incubated with GST-C-CPE313 (data not shown). These results suggest that TJs of the TE are partially disturbed in GST-C-CPE-treated embryos because of the loss of claudin 4 and 6 from TJs.
Previous studies have indicated that Na + /K + -ATPases and aquaporin water channels within the plasma membrane of the TE are involved in blastocoel cavity formation . To exclude the possibility that GST-C-CPE affects these transporters, we examined their expression and localization by immunofluorescence staining. In control embryos, both the Na + /K + -ATPase α1 subunit and aquaporin 3 were localized at the basolateral plasma membrane of the TE of E4.0 embryos (Figs. 6A, B) . In GST-C-CPE-treated embryos, these transporters were localized at the basolateral plasma membrane of the outer cells (TE-like cells), similar to those in control embryos, although these cells showed a rounded shape (Figs. 6A, B) . This suggests that the molecular targets of the GST-C-CPE action are claudins, not Na + /K + -ATPases or aquaporin water channels.
Effect of GST-C-CPE treatment on cell differentiation in blastocysts
GST-C-CPE treatment disrupted the barrier function of the TE, indicating that the solution environment of the blastocoelic fluid was also affected in these embryos. Abnormal blastocoelic fluid may influence cell fate and differentiation in blastocysts. To address this issue, we examined the expression of Oct3/4 and Cdx2, which are markers of pluripotency and TE differentiation, respectively (Fig. 7) . In normal cultured embryos, Oct3/4 expression was initially observed in all blastomeres (data not shown). It was down-regulated in the Cdx2-positive TE lineage during the early blastocyst stage and became restricted to the ICM by E4.0 (Fig. 7A) , as described previously (Stumpf et al., 2005; Niwa et al., 2005) . By contrast, in GST-C-CPE-treated embryos with a blastocoel cavity, although Cdx2 was normally expressed in the outer blastomeres (TE-like cells), Oct3/4 was expressed in all cells, including the outer cells, at E4.0 (Figs.  7B, C) . However, at E5.5, Oct3/4 could not be detected in the Cdx2-positive blastomeres of the GST-C-CPE-treated embryos (Fig. 7D) . These results indicate that the disruption of the barrier function of the TE causes the significant developmental delay of blastocysts, although it does not affect the final differentiation of the TE itself and the ICM in terms of the expression of Cdx2 and Oct3/4.
Discussion
Accumulating evidence has revealed that claudin family of membrane proteins plays key roles in the structure and function of TJs, implying that claudins are good targets through which to modify the barrier function of TJs by a molecular biological approach. Here, we found that TJs in the mouse TE consist of claudin 4, 6, and 7 at least, among which claudin 4 and 6 bind to GST-C-CPE, a claudin inhibitory polypeptide. Using IVFderived mouse early embryos, we demonstrated that the cavitation of the blastocoel was perturbed by GST-C-CPE treatment, accompanied by dysfunction of the TJ barrier of the TE and loss of claudin 4 and 6 from TJs. These findings demonstrate for the first time that the barrier function of TJs in the TE is required for normal blastocyst formation. This study also suggests that the barrier function of TJs is indeed involved in the morphogenetic events caused by hydrostatic pressure during developmental processes.
We previously reported that C-CPE can be utilized as an inhibitor of TJ formation. C-CPE directly binds to the second extracellular loop of some claudin family members, including claudin 4, which was originally identified as a cellular receptor of CPE (Katahira et al., 1997a) . When C-CPE was added to MDCK I cells expressing at least claudin 1 and 4, claudin 4 was down-regulated from TJs accompanied by disorganization of TJ strands and a remarkable reduction in the barrier function of the cellular sheet (Sonoda et al., 1999) . In the present study, we generated a GST-C-CPE fusion protein to use as a claudin inhibitor. The action of GST-C-CPE seemed to be very specific to the susceptible claudins, whose localizations at TJs were markedly affected by GST-C-CPE treatment with disruption of the TJ barrier. In addition, GST-C-CPE313, which is a six amino acid deletion construct of C-CPE, appeared not to influence blastocyst formation. These results confirmed the suitability of GST-C-CPE as a specific inhibitor to the barrier function of TJs. Furthermore, the expression and basolateral localization of the Na + /K + -ATPase α1 subunit and aquaporin 3, which are believed to be involved in blastocyst formation, were not affected by GST-C-CPE treatment. This observation suggested that the apico-basal polarity of the TE was maintained in GST-C-CPEtreated embryos and that other subtypes of Na + /K + -ATPase subunits and aquaporins expressed in the TE also show normal localization on plasma membrane domains. Considering these Fig. 4 . Effects of GST-C-CPE on the barrier function of the TE. (A) Normal cultured embryos at E3.0, E3.25, and E3.5 incubated in medium containing FITC-dextran (4.4 kDa) for 10 min were examined by confocal microscopy and phase-contrast microscopy (lower and upper panels, respectively). In embryos at E3.25, intense fluorescent signal of FITC-dextran was observed in the blastocoel as well as in the culture medium surrounding embryos, indicating the influx of FITC-dextran into the blastocoel (E3.25 in upper panels) from the medium. By contrast, at E3.5, slight penetration of FITC-dextran into the blastocoel was observed in some embryos but not others (E3.5, left and right, respectively, in upper panels), suggesting that the TE barrier was established around this stage. (B) The influx of FITC-dextran was compared between GST-C-CPE-treated and GST-C-CPE313-treated embryos at E4.0. In GST-C-CPE313-treated embryos, the influx of FITC-dextran was hardly detected at E4.0. By contrast, obvious penetration of FITC-dextran into the blastocoel was observed even at E4.0, not only in GST-C-CPE-treated type I embryos, which had rounded blastomeres and an undetectable or very small blastocoel, but also in GST-C-CPE-treated type II embryos, which had smooth blastomeres and an immature blastocoel. Scale bars, 20 μm. results together, it is reasonable to conclude that GST-C-CPE directly binds to the extracellular domain of claudin 4 and 6 in the TE and perturbs their TJ-forming activity, leading to dysfunction of the TE barrier. Claudin molecules associate with each other between adjacent cells and concomitantly assemble into fibril-like structures within the plasma membrane to form TJ strands (Furuse et al., 1998b) . Therefore, GST-C-CPE binding to the extracellular domain of claudin 4 and 6 may prevent these claudins from being incorporated into TJ strands because of steric hindrance or the conformational change in these claudins. Alternatively, GST-C-CPE binding may induce the down-regulation of these claudins from the plasma membrane (Sonoda et al., 1999) .
In GST-C-CPE-treated embryos, claudin 4 and 6 were not assembled into TJs in the TE, while claudin 7 was linearly concentrated at the most apical region of the lateral membrane with occludin. This suggests that GST-C-CPE-treated mouse embryos can form continuous TJs containing at least claudin 7 at the immunofluorescence staining level. It is now widely accepted that the difference in the combination and the mixing ratio of claudins creates functional diversity of tight junctions; for example, in terms of conductance and charge selectivity (Van Itallie and Anderson, 2005; Furuse and Tsukita, 2006) . In this study, however, TJs in GST-C-CPE-treated blastocysts probably had destructive breaks since even fluorescein dextran of 4.4 kDa could easily penetrate into the paracellular space. Similar dysfunction of the TJ barrier was observed in several claudin gene knock-out mice. In claudin 1-deficient mice, the barrier function of TJs in the keratinocytes of epidermis was remarkably disrupted, and a water-soluble tracer with a molecular mass of ∼ 500 Da easily penetrated these TJs (Furuse et al., 2002) . However, epidermal keratinocytes in these mice retained TJs composed of claudin 4 at least (Furuse et al., 2002) . Claudin 5-deficient mice also showed remarkable disruption of the barrier function of the TJs in brain endothelial cells, which normally express at least claudin 5 (Nitta et al., 2003) . In these mice, the barrier function of TJs to a tracer with a molecular mass of ∼ 800 Da was severely disrupted, leading to dysfunction of the blood-brain barrier, even though TJs were observed in brain endothelial cells by ultrathin section electron microscopy (Nitta et al., 2003) . In all cases, including that of GST-C-CPE-treated mouse blastocysts, continuous TJs appeared to be formed, but their barrier functions were remarkably disrupted. Although the molecular mechanism underlying this discrepancy remains elusive, one possibility is that GST-C-CPE treatment or disruption of a claudin gene may lead to a deficiency in the levels of claudin molecules such that TJ strands have partial breaks. Alternatively, the change in claudin species in TJs may cause a change in the balance of dynamic behavior of TJ strands (such as end-to-end or end-to-side breaking and annealing) resulting in the acceleration of paracellular transport of solutes . To address this issue, detailed morphological analyses should be performed by freeze-fracture replica electron microscopy in future studies.
Another important point is whether the separation of the fluid compartment is required for the growth, viability, and differentiation of cells during the developmental process. In claudin 14 null mice, a model for human autosomal recessive deafness, cochlear hair cells differentiate normally but degenerate later during the first 3 weeks of life (Ben-Yosef et al., 2003) . In the organ of Corti in the inner ear in mice, claudin 14 is a component of TJs of the reticular lamina, which separates K + -rich endolymph and Na + -rich perilymph. One explanation for the phenotype of claudin 14-deficient mice is that the disruption of the cochlear barrier results in the backflow of high K + solution in the endolymph to the compartment of perilymph (Ben-Yosef et al., 2003) . This could lead to the exposure of the basolateral membrane domain of hair cells to a relatively high K + solution, which is toxic to these cells (Boettger et al., 2002) . In this study, GST-C-CPE treatment induced slight retardation of cell growth, but its mechanism remains elusive. In contrast to our initial speculation, the ICM and the TE underwent almost normal differentiation in terms of the expression of Cdx2, a TE differentiation marker, and Oct3/ 4, a pluripotency marker (Beck et al., 1995; Palmieri et al., 1994; Mitsui et al., 2003; Stumpf et al., 2005) , although downregulation of Oct3/4 from the outer blastomeres (TE-like cells) was retarded. It is of interest whether further development of the embryo is affected by GST-C-CPE treatment, but, Fig. 5 . Immunolocalization of claudins in the TE of GST-C-CPE-treated embryos. GST-C-CPE-treated E4.0-stage embryos were double-stained with pAbs for claudin 4, 6, or 7 and anti-occludin mAb. In GST-C-CPE-treated embryos, claudin 4 and 6 disappeared from TJs of the TE (arrowheads), but claudin 7 retained its continuous localization. Occludin concentration was not affected by GST-C-CPE-treatment. Scale bars, 20 μm.
unfortunately, we could not analyze this with in vitro-cultured mouse embryos because of technical limitations. Application of GST-C-CPE to other developmental systems, such as chick or zebrafish embryos, would be useful to elucidate the role of TJs in morphogenetic events and cell differentiation during early development.
Kim and colleagues have reported that occludin, a transmembrane protein of TJs, is involved in normal blastocyst formation (Kim et al., 2004) . They cultured eight-cell embryos and morulae in the presence of a commercial anti-occludin antibody raised against the C-terminal cytoplasmic region and found that this treatment inhibited blastocoel formation and increased the permeability of the TE of nascent and expanding blastocysts to FITC-dextran of 4 kDa. It is difficult to understand how this antibody acted on occludin in the TE cells of live embryos from the culture medium. Occludin-deficient mice are born normally (Saitou et al., 2000) and we observed that occludin-null embryos without maternal occludin, generated by IVF using occludin−/− eggs and occludin+/− sperm, underwent blastocoel expansion (K. Moriwaki and M. Furuse, unpublished) . Therefore, further investigation is needed to clarify the role of occludin in the barrier function of the TE during blastocyst formation.
In summary, we have shown that blastocoel expansion during mouse blastocyst formation was perturbed by GST-C-CPE, a claudin inhibitory polypeptide, accompanied by Fig. 6 . Immunolocalization of Na + /K + -ATPase and aquaporin 3 in GST-C-CPE-treated embryos. The Na + /K + -ATPase α1 subunit (A) and aquaporin 3 (B) were localized at the basolateral membrane of the TE in GST-C-CPE313-treated (control) blastocysts at E4.0 (arrowheads). In GST-C-CPE-treated embryos, both transporter proteins in the blastomeres were mostly localized at the basolateral membrane (arrowheads), the lumen of the cavity, although the cells exhibited a rounded shape without expansion. Arrows indicate occludin concentration at TJs, which separates apical and basolateral membrane domains. Scale bars, 20 μm.
dysfunction of the TJ barrier of the TE and loss of claudin 4 and 6 from TJs. This study for the first time demonstrates that the barrier function of TJs in the TE is required for normal blastocyst formation. Future applications of GST-C-CPE to various experimental systems would clarify the role of TJs during developmental processes.
